ChargePoint Technology and STERIS collaborate to bring sterile solutions for Evonik

Evonik will be provided with sterile solutions from a collaboration between ChargePoint Technology Group and STERIS, utilising ChargePoint’s AseptiSafe Bio Valve and STERIS’ bio-decontamination systems.

At its plant in Alabama, USA, Evonik manufactures complex parenteral medications using fill-finish lines handling a broad mix of products. Evonik will be utilising ChargePoint’s AseptiSafe® Bio Valve, which will be coupled to the STERIS Vaporised Hydrogen Peroxide bio-decontamination system. Optimised for continuous filling, the line will allow chemical products to move through processes rapidly and efficiently. Product transfer from a container to filling equipment maintained in a sterile environment will also be achieved through the solution. In addition, the ChargePoint AseptiSafe Split Butterfly Valve will securely connect the product and the container, further protecting sterility and the integrity of the API.  

CEO of ChargePoint Technology Chris Eccles commented: “With the development of specialised medicines increasing, many manufacturers like Evonik have struggled to find specialised equipment that meet their requirements. It was absolutely crucial that Evonik could aseptically connect and disconnect the product vessel quickly to maintain product sterility. After reviewing multiple vendors, our system was found to provide the highest degree of product protection.” 

The VHP 1000ED bio-decontamination unit from STERIS possesses the ability to decontaminate its surroundings and adapts easily to the manufacturing environment. By combining the abilities of ChargePoint and STERIS’ technologies, replacing product containers during manufacturing can occur aseptically within 1 hour while enabling continuous filling, further minimising downtime.  

Caroline Hand, Production Engineer at Evonik, stated: “Evonik has been delighted by the results produced the multifaceted approach from ChargePoint and STERIS This partnership provided a solution that delivered the highest integrity when performing high volume aseptic product transfer with multiple product containers and significantly reduced the turnaround time of this project. We are thrilled with the outcomes.” 

Associate Product Manager Abby Lovell from STERIS added: “Our continued partnership with ChargePoint means that its unique aseptic SBV technology in conjunction with STERIS’ VHP bio-decontamination system are collectively meeting the technical needs of the industry. This has allowed us to provide the ultimate sterile transfer solution to Evonik and we look forward to many more years of partnership.”